Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib Maintenance in Stage IIIb NSCLC
NCT00274898Phase 2Unknown
- Sponsor
- GERCOR
- Start
- May 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in non-small cell lung cancer (NSCLC), sponsored by GERCOR. Status: unknown.
02
Drugs
celecoxib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00274898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274898.